Ticker Details
Atyr Pharma, Inc.
IPO Date:	May 12, 2015
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$69.43M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.11 | 3.64%
Avg Daily Range (30 D):	$0.02 | 3.14%
Avg Daily Range (90 D):	$0.05 | 4.13%

Institutional Daily Volume
Avg Daily Volume:	.43M
Avg Daily Volume (30 D):	1.5M
Avg Daily Volume (90 D):	7.16M

Trade Size
Avg Trade Size (Sh.):	260
Avg Trade Size (Sh.) (30 D):	300
Avg Trade Size (Sh.) (90 D):	435

Institutional Trades
Total Institutional Trades:	124
Avg Institutional Trade:	$1.71M
Avg Institutional Trade (30 D):	$1.67M
Avg Institutional Trade (90 D):	$1.5M
Avg Institutional Trade Volume:	.52M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.68M
Avg Closing Trade (30 D):	$2.74M
Avg Closing Trade (90 D):	$1.64M
Avg Closing Volume:	507.37K

News

Dec 6, 2025 @ 5:58 PM ATYR Lawsuit: Hagens Berman Urges aTyr Pharma Inve... Source: Reed Kathrein

Dec 6, 2025 @ 1:53 PM ATYR CLASS ACTION DEADLINE ALERT: Bragar Eagel & S... Source: Bragar Eagel & Squire, P.C.

Dec 6, 2025 @ 2:38 AM מועד אחרון לת... Source: Rosen Law Firm

Dec 5, 2025 @ 10:57 PM ATYR DEADLINE MONDAY: ROSEN, A GLOBALLY RESPECTED ... Source: Rosen Law Firm

Dec 5, 2025 @ 5:00 PM ATYR INVESTOR ALERT: Bronstein, Gewirtz & Grossman... Source: Bronstein, Gewirtz & Grossman Llc

Financials
	TTM	Q2 2025	Q1 2025
Basic EPS	$-.26	$-.22	$-.17
Diluted EPS	$-.26	$-.22	$-.17
Revenue	$.19M	$M	$M
Gross Profit
Net Income / Loss	$-25.75M	$-19.53M	$-14.88M
Operating Income / Loss	$-26.75M	$-20.31M	$-15.77M
Cost of Revenue
Net Cash Flow	$-11.24M	$7.3M	$-1.21M
PE Ratio